Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Definium Therapeutics, Inc.
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum d… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: July 11, 2022
Headquarters: One World Trade Center, New York, NY, United States, 10007
Founder-Led: Yes — Scott Freeman (Co-Founder & Clinical Advisor), Leonard Latchman (Co-Founder)
Key Metrics
Current Price
$22.05
Market Cap
$2.53B
Float
98.8M
Shares Outstanding
109.1M
Dividend Rate
None
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
N/A
-$34.1M
N/A
-$33.6M
2021
N/A
-$93.0M
N/A
-$91.2M
2022
N/A
-$56.8M
N/A
-$63.2M
2023
N/A
-$95.7M
-$3.2M
-$92.6M
2024
N/A
-$109M
-$527,000
-$106M
2025
N/A
-$184M
N/A
-$178M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Mar 2025
N/A
-$23.3M
Jun 2025
N/A
-$42.7M
Sep 2025
N/A
-$67.3M
Dec 2025
N/A
-$50.4M
Ownership & Float
Insider Ownership
0.9%
Institutional Ownership
66.7%
Short Float
9.9%
% of All Funds Holding
2.20%
Number of Funds Holding
170
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$20.31
Near-term / short-term trend
Weekly
40-Week SMA
$14.64
Medium-term trend
Weekly
80-Week SMA
$10.93
Cyclical trend (business cycle)
Weekly
200-Week SMA
$7.53
Secular trend (multi-year)
Monthly
10-Month SMA
$15.81
Near-term monthly trend
Monthly
20-Month SMA
$11.40
Medium-term monthly trend
Monthly
40-Month SMA
$8.33
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$13.50
support
1.39x
3 months ago
$11.70
support
1.52x
6 months ago
$8.80
support
1.02x
7 months ago
Historical Earnings Reactions (35 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
1.66%
0.00%
45.71%
34.27%
-13.46%
1 Day
0.53%
0.00%
40.00%
17.48%
-13.46%
1 Week
5.07%
-2.73%
42.86%
71.15%
-15.47%
2 Weeks
3.13%
-3.27%
45.71%
60.78%
-23.53%
1 Month
8.69%
-3.49%
37.14%
223.53%
-31.03%
Next earnings: May 14, 2026 (3 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
6.4%
50.0%
10
Feb
10.0%
70.0%
10
Mar
104.3%
50.0%
10
Apr
2.1%
60.0%
10
May
-5.1%
22.2%
9
Jun
-10.0%
44.4%
9
Jul
-2.0%
44.4%
9
Aug
39.1%
44.4%
9
Sep
-4.2%
33.3%
9
Oct
5.2%
66.7%
9
Nov
6.8%
33.3%
9
Dec
10.6%
60.0%
10
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.67%
42.1%
444
Tuesday
1.40%
41.9%
489
Wednesday
1.08%
38.6%
487
Thursday
0.10%
40.6%
478
Friday
9.97%
42.2%
479
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 66.7%
Insider Transactions — Smart Summary
Total insider ownership: 0.9%
Founder-led management: Scott Freeman (Co-Founder & Clinical Advisor), Leonard Latchman (Co-Founder)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Definium Therapeutics, Inc.
(DFTX) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.